OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 01/06/2023
Week ended 01/06/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 01/06/2023
The Week’s Largest Closed Equity Transaction:
- On January 4, 2023, Atlas Global Brands (expected symbol ATL: CSE) completed a 100,000 share issuance of stock in its Cambrosia subsidiary for approximately US$2.55M.
- Concurrent with the capital raise, Atlas completed an RTO and business combination of Atlas Biotech (a licensed cultivator and processor in Canada), AgMedica (an EU-GMP certified processor and exporter of cannabis flower and oil), and Cambrosia (an Israel-based group with owned pharmaceutical distribution).
- The combined companies formed a vertically integrated unit that serves eight countries.
- According to filed Form 2A, the combined companies had a proforma EBITDA for the nine months ended 9/30/22 of approximately negative C$7.4M. However, this gives no effect to synergies from internal sourcing of biomass or the potential to significantly increase exports to Israel.
- We believe reasonable valuation analysis needs to be deferred until the combined company begins trading on the CSE next week.
Public vs. Private Raises:
- One of this week’s two capital-raising companies will begin trading on the CSE on January 15, 2023.
Equity vs. Debt Cap Raises:
- Equity accounted for all of this week’s capital raises.
Week ended 01/06/2023
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 01/06/2023
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 01/06/2023
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.